Ferti®-M

Ferti Care Ferti® MFerti Care Ferti® M

Composition:

Each vial contains 75 International Units (IU) of follicle-stimulating hormone (FSH) activity and 75 IU of luteinizing hormone (LH) activity.

Indication:

Menotropin, in conjunction with HCG, is indicated for primary or secondary menostasiain induced by secretion deficiency of gonadotropins and fertilitiesfeminis induced by anovulation.

Dosage:

Intramuscular injection Dissolve HMG in 1 to 2 ml of chloride sodium injection. For the start (the 5th day of period), 75IU to 150IU is given, once a day. After 7 day, the dosage is adjusted in terms of estrogen level and follicle growth and the dose increases to 150 to 225IU daily.

ADVERSE REACTION

Mainly Ovarian Hyper-stimulation Syndrome, showing the symptom like nausea, vomiting, diarrhea, abdominal pain and ovarian enlargement. Severe symptoms are chest distress, pleural fluid, abdominal fluid, oliguria's even ovary cyst rupture bleeding. Multiple pregnancy and premature delivery are rarely occurred.

CONTRA-INDICATIONS:

Patients with hypersensitivity, ovary presenility, menopause, unclear vaginal bleeding, hysteromyoma, ovary cyst and ovary enlargement are contraindicated.

PRECAUTIONS:

Pregnancy and lactation:

Contraindicated.

Specification

75IU, 150IU
Storage:Protect from light and keep tightly sealed in a cool place.